Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhengye Biotechnology HoldingZYBT -1.03%20 PS Ratio is 5.59 as of Aug. 25, 2026, which is 14% above its 10-year median of 4.92. GuruFocus rates ZYBT with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 950 Drug Manufacturers companies, Zhengye Biotechnology Holding ranks worse than 76.32% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Zhengye Biotechnology Holding's share price is $1.93.
Zhengye Biotechnology Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.35. Hence, Zhengye Biotechnology Holding's PS Ratio for today is 5.59.
The historical rank and industry rank for Zhengye Biotechnology Holding's PS Ratio or its related term are showing as below:
ZYBT'
s PS Ratio Range Over the Past 10 Years
Min: 1.85 Med: 4.92 Max: 24.83
Current: 5.58
During the past 5 years, Zhengye Biotechnology Holding's highest PS Ratio was 24.83. The lowest was 1.85. And the median was 4.92.
ZYBT's PS Ratio is ranked worse than 76.32% of 950
companies
in the Drug Manufacturers industry
Industry Median: 2.39
vs ZYBT: 5.58
During the past 5 years, Zhengye Biotechnology Holding's highest 3-Year average Revenue per Share Growth Rate was -8.70% per year. The lowest was -23.90% per year. And the median was -16.30% per year.
Zhengye Biotechnology Holding (NAS:ZYBT) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Zhengye Biotechnology Holding PS Ratio Related Terms
Zhengye Biotechnology Holding PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhengye Biotechnology Holding's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhengye Biotechnology Holding PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhengye Biotechnology Holding's PS Ratio distribution charts can be found below:
* The bar in red indicates where Zhengye Biotechnology Holding's PS Ratio falls into.
Zhengye Biotechnology Holding PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Zhengye Biotechnology Holding's Share Price of today is $1.93.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Zhengye Biotechnology Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.35.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Zhengye Biotechnology Holding (ZYBT) has a PS Ratio of 5.59 as of Aug. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Zhengye Biotechnology Holding and its competitors. This is 14% above median its historical median of 4.92. Over the past decade, Zhengye Biotechnology Holding's PS Ratio has ranged from 1.85 to 24.83. According to the industry distribution chart, Zhengye Biotechnology Holding ranks #725 out of 950 companies in the Drug Manufacturers industry, placing it in the top 76.3%.
Is Zhengye Biotechnology Holding's PS Ratio too high?
Zhengye Biotechnology Holding's current PS Ratio of 5.59 is 14% above median its 10-year median of 4.92. Over the past 10 years, this metric has ranged from a low of 1.85 to a high of 24.83. The Drug Manufacturers industry median PS Ratio is 2.39. Zhengye Biotechnology Holding's value of 5.59 is 133.9% above this industry median. Based on the distribution chart, Zhengye Biotechnology Holding ranks #725 out of 950 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Zhengye Biotechnology Holding has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Zhengye Biotechnology Holding's PS Ratio compare to TLPH and CPHI?
According to the Drug Manufacturers industry distribution chart, Zhengye Biotechnology Holding ranks #725 out of 950 companies for PS Ratio. This places Zhengye Biotechnology Holding in the lower half of its industry. The industry median PS Ratio is 2.39. Zhengye Biotechnology Holding's value of 5.59 is 133.9% above this benchmark. Historically, Zhengye Biotechnology Holding's own PS Ratio has ranged from 1.85 to 24.83 over the past decade. While the company's 10-year median is 4.92 vs. the industry median of 2.39, Zhengye Biotechnology Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.39, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhengye Biotechnology Holding's current PS Ratio of 5.59 is 133.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Zhengye Biotechnology Holding and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhengye Biotechnology Holding's current PS Ratio is 5.59, which is 14% above median its own 10-year median of 4.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhengye Biotechnology Holding stock overvalued right now?
Zhengye Biotechnology Holding (ZYBT) has a current PS Ratio of 5.59. The current PS Ratio is 5.59, which is 14% above median its 10-year median of 4.92 and 133.9% above the Drug Manufacturers industry median of 2.39. Zhengye Biotechnology Holding's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Zhengye Biotechnology Holding (ZYBT), the current PS Ratio is 5.59 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
20GF Score
Get the complete analysis for ZYBT
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZYBT has been successfully added to your 
